home / stock / clsd / clsd articles

CLSD Articles, Clearside Biomedical Inc. - From 03/18/24

Stock Information
Company Name: Clearside Biomedical Inc.
Stock Symbol: CLSD
Market: NASDAQ
Website: clearsidebio.com
Menu
CLSD CLSD Quote CLSD Short CLSD News CLSD Articles CLSD Message Board
Get CLSD Alerts

News, Short Squeeze, Breakout and More Instantly...
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer | Benzinga

ALPHARETTA, Ga., March 18, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the d...
Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024 | Benzinga

ALPHARETTA, Ga., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the de...

Top 5 Health Care Stocks That May Crash This Month | Benzinga

As of Jan. 22, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in th...

Ocular Gene Therapy: Regenxbio Data Shows Consistent Preservation Of Visual Acuity, Retinal Thickness | Benzinga

Regenxbio Inc (NASDAQ:RGNX) released Tuesday, Jan. 16, interim data from the Phase 2 AAVIATE trial of ABBV-RGX-314 for wet age-related macular deg...
Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Update | Benzinga

- New Licensing Partnership with BioCryst Pharmaceuticals Expands Clearside's Proprietary Suprachoroidal Injection Platform to Plasma Kallikr...

Clearside Biomedical to Participate in Fireside Chat at the Stifel 2023 Healthcare Conference | Benzinga

ALPHARETTA, Ga., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the de...

Clearside Biomedical's Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic Indications in Clinical Data Presentations at AAO 2023 Annual Meeting | Benzinga

ALPHARETTA, Ga., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the de...
Clearside Biomedical Insider Trades Send a Signal | Benzinga

Bradford T Whitmore, 10% Owner at Clearside Biomedical (NASDAQ:CLSD), reported a large insider buy on November 1, according to a new SEC filing. W...

Over $2M Bet On Community Health Systems? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying | Benzinga

The Dow Jones closed higher by over 200 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around...

Clearside Biomedical Announces Presentations at the American Academy of Ophthalmology 2023 Annual Meeting | Benzinga

ALPHARETTA, Ga., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the de...
Previous 10 Next 10